We propose that this difference may be related to the compensatory vasoregulatory mechanisms that are upregulated during chronic NO deficiency in the NOS1/3 DKO animals, and probably explain the milder hypertension in NOS KO compared to L-NAME-treated mice. This evidence concerns the gene NOS1 and hypertensive disorder.